Pliant Therapeutics

Pliant Therapeutics

CA - South SF
Biotechnology

Focus: Treatments for fibrotic diseases

Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.

RespiratoryOncology
Open Jobs
1

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT03183570Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT
Phase 1
Phase 1
Clinical Trials (1)
NCT06270706A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1
Clinical Trials (1)
NCT04396756Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis
Phase 2
Clinical Trials (1)
NCT04480840Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
Phase 2
Clinical Trials (1)
NCT05621252Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)
Phase 2
Clinical Trials (1)
NCT04565249Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19
Phase 2
Clinical Trials (1)
NCT04072315Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/
Phase 2
Clinical Trials (1)
NCT06097260Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
Phase 2

Open Jobs (1)

Interview Prep Quick Facts
Portfolio: 8 clinical trials
Top TAs: Respiratory, Infectious Diseases, Oncology
Open Roles: 1 active job
Therapeutic Area Focus
Respiratory
6 pipeline
Oncology
1 pipeline
Marketed
Pipeline

Hiring Trend

Stable
1
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles